Sarah Lonergan
- Co-authors
- David J. ChaplinStephen HillJ. DenekampPieter SonneveldSonja ZweegmanEdo VellengaOkke de WeerdtMarie José Kersten
- Topics
- Multiple Myeloma Research and Treatments (11 papers)Cancer Treatment and Pharmacology (8 papers)Protein Degradation and Inhibitors (6 papers)
- Cited by
- HematologyOncologyCancer Research
- Journals
- Journal of Clinical OncologyBloodInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- NetherlandsItalyUnited States
In The Last Decade
Sarah Lonergan
13 papers receiving 339 citations
Peers
Comparison fields: 5 of 46
- Molecular Biology 262
- Hematology 169
- Oncology 145
- Cancer Research 61
- Pulmonary and Respiratory Medicine 26
Countries citing papers authored by Sarah Lonergan
This map shows the geographic impact of Sarah Lonergan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Lonergan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Lonergan more than expected).
Fields of papers citing papers by Sarah Lonergan
This network shows the impact of papers produced by Sarah Lonergan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Lonergan. The network helps show where Sarah Lonergan may publish in the future.
Co-authorship network of co-authors of Sarah Lonergan
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Lonergan. A scholar is included among the top collaborators of Sarah Lonergan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Lonergan. Sarah Lonergan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 0 | |
| 3 | 22 | |
| 4 | 31 | |
| 5 | A phase II study of selinexor(KPT-330) combined with bortezomib and dexamethasone (SVD) for induction and consolidation for patients with progressive or refractory multiple myeloma: The selvedex trial | 5 |
| 6 | 9 | |
| 7 | 1 | |
| 8 | 48 | |
| 9 | 9 | |
| 10 | 17 | |
| 11 | 16 | |
| 12 | 11 | |
| 13 | 19 | |
| 14 | 153 |
About Sarah Lonergan
Sarah Lonergan is a scholar working on Hematology, Oncology and Biochemistry, having authored 14 papers that have together received 350 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Cancer Treatment and Pharmacology (8 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Hematology (169 citations), Oncology (145 citations) and Cancer Research (61 citations). Sarah Lonergan has collaborated with scholars based in Netherlands, Italy and United States. Frequent co-authors include David J. Chaplin, Stephen Hill, J. Denekamp, Pieter Sonneveld, Sonja Zweegman, Edo Vellenga, Okke de Weerdt, Marie José Kersten, Henk M. Lokhorst and Bronno van der Holt. Their work appears in journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.